izpis_h1_title_alt

Amniotic membrane preparation crucially affects its broad-spectrum activity against uropathogenic bacteria
ID Železnik Ramuta, Taja (Author), ID Starčič Erjavec, Marjanca (Author), ID Erdani-Kreft, Mateja (Author)

.pdfPDF - Presentation file, Download (3,22 MB)
MD5: B07ADFF789288F68C9FD4A1D766CAB82
URLURL - Source URL, Visit https://www.frontiersin.org/articles/10.3389/fmicb.2020.00469/full This link opens in a new window

Abstract
Urinary tract infections are among the most common bacterial infections in humans. Moreover, they are highly recurrent and increasingly often resistant to antibiotics. The antimicrobial properties of the amniotic membrane (AM), the innermost layer of fetal membranes, have been briefly reported in the literature, however, the results of published studies are often inconsistent and unclear; moreover, its effect on uropathogenic bacteria has not yet been investigated. Further, there is no data in the literature about the effect of AM preparation and storage on its antimicrobial properties. To examine the impact of several preparation procedures on the antimicrobial properties of AM, we prepared patches and homogenates of fresh (fAM) and cryopreserved (cAM) human AM and tested them on 14 selected Gram-positive and Gram-negative uropathogenic bacteria. By employing novel antimicrobial efficiency assays we showed that fAM and cAM homogenates have broad-spectrum antimicrobial activity against all here tested uropathogenic bacteria, except for Serratia marcescens. Moreover, they had a potent effect also on the multiple-resistant clinical strains of uropathogenic Escherichia coli. Interestingly, the patches of fAM and cAM had no antimicrobial effect on any of the tested strains. We therefore prepared and stored AM patches according to the standard procedure for clinical use in ophthalmology, which includes the cryopreservation of antibiotic-treated AM, and performed antimicrobial efficiency assays. Our findings suggest that the ultrastructure of AM patches could enable the retention of added antibiotics. In addition, we also prepared gentamicin-resistant uropathogenic E. coli strains, which confirmed that the antimicrobial effect of antibiotic-treated AM patches can be attributed to the antibiotic alone. To summarize, here we describe novel protocols for preparation and storage of AM to ensure the preservation of its antimicrobial factors. Moreover, we describe the mechanism of AM retention of antibiotics, based on which the AM could potentially be used as a drug delivery vehicle in future clinically applicable approaches.

Language:English
Keywords:amniotic membrane, uropathogenic bacteria, antimicrobial effect, broad-spectrum, microscopy, ultrastructure, homogenate, patches
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:17 str.
Numbering:Vol. 11, art. 469
PID:20.500.12556/RUL-128785 This link opens in a new window
UDC:616.6
ISSN on article:1664-302X
DOI:10.3389/fmicb.2020.00469 This link opens in a new window
COBISS.SI-ID:34747609 This link opens in a new window
Publication date in RUL:29.07.2021
Views:1373
Downloads:163
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Frontiers in microbiology
Shortened title:Front. microbiol.
Publisher:Frontiers Media
ISSN:1664-302X
COBISS.SI-ID:4146296 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:24.03.2020

Secondary language

Language:Slovenian
Keywords:amnijska membrana, uropatogene bakterije, protimikrobni učinek

Projects

Funder:ARRS - Slovenian Research Agency
Funding programme:Young-researcher funding

Funder:ARRS - Slovenian Research Agency
Project number:J3-7494
Name:Tunelske membranske nanocevke za inovativno zdravljenje raka sečnega mehurja

Funder:ARRS - Slovenian Research Agency
Project number:P3-0108
Name:Diferenciacija urotelijskih celic

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back